10x Genomics, Inc. (TXG)
After hours:
| Previous close | 19.92 |
| Open | 20.15 |
| Bid | 20.20 x 1200 |
| Ask | 20.26 x 600 |
| Day's range | 19.71 - 20.80 |
| 52-week range | 15.28 - 63.57 |
| Volume | |
| Avg. volume | 1,909,533 |
| Market cap | 2.42B |
| Beta (5Y monthly) | 1.84 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.24 |
| Earnings date | 08 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 29.57 |
Insider Monkey10x Genomics, Inc. (TXG): Hedge Funds Think This Stock Will Skyrocket
We recently compiled a list of the 10 Stocks That Will Skyrocket. In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other stocks. The primary lure of investing, as you’re likely to know, is to make money. Every day thousands of investors pour into the market […]
ZacksFulgent Genetics (FLGT) Soars 6.6%: Is Further Upside Left in the Stock?
Fulgent Genetics (FLGT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ZacksDoes 10x Genomics (TXG) Have the Potential to Rally 85.65% as Wall Street Analysts Expect?
The consensus price target hints at an 85.7% upside potential for 10x Genomics (TXG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
